SUPN SUPERNUS PHARMACEUTICALS, INC.
Nasdaq · SEC CIK 1356576 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $17.49M 15 sales by 8 insiders
- Filings on record
- 279 since 2021-07-30, latest 2026-08-14 17:12
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Khattar Jack A. | Pres, CEO, Dir | — | $7.72M |
| Bhatt Padmanabh P. | CSO, SVP of IP | — | $5.42M |
| NEWHALL CHARLES W III | Dir | — | $1.27M |
| Mottola Frank | SVP, Chief Tech. Ops. Off | — | $1.10M |
| GEMAYEL GEORGES | Dir | — | $1.00M |
| Horich William Todd | SVP, Commercial Ops | — | $483.8K |
| Hudson Frederick M. | Dir | — | $271.7K |
| Sensenig Bethany | Dir | — | $228.3K |
| Rubin Jonathan | SVP, Chief Medical Off | — | — |
| Barlow Carrolee | Dir | — | — |
Transactions 317
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-03 | 2025-04-02 | SUPN | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | +16.9K | 1.01M | +2% | — | |
| I | 2025-04-03 | 2025-04-02 | SUPN | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | -16.9K | 1.01M | -2% | — |
| D | 2025-03-11 | 2025-03-10 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +35.0K | 1.01M | +4% | $0 |
| D | 2025-03-11 | 2025-03-10 | SUPN | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $32.06 | -16.8K | 991.8K | -2% | -$538.8K |
| DM | 2025-03-11 | 2025-03-10 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | F - Tax | $32.06 | -2,017 | 12.7K | -14% | -$64.7K |
| DM | 2025-03-11 | 2025-03-10 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | M - OptEx | $0.00 | +3,800 | 13.6K | +39% | $0 |
| D | 2025-03-07 | 2025-03-07 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +38.6K | 992.2K | +4% | $0 |
| D | 2025-03-07 | 2025-03-07 | SUPN | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $39.11 | -18.6K | 973.6K | -2% | -$726.7K |
| D | 2025-03-07 | 2025-03-07 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $0.00 | +2,625 | 16.5K | +19% | $0 |
| D | 2025-03-07 | 2025-03-07 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F - Tax | $39.11 | -1,356 | 15.2K | -8% | -$53.0K |
| M | 2025-03-05 | 2025-03-05 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $33.05 | -1,468 | 9,635 | -13% | -$48.5K |
| M | 2025-03-05 | 2025-03-05 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $33.05 | -1,485 | 13.9K | -10% | -$49.1K |
| M | 2025-03-05 | 2025-03-05 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | F - Tax | $33.05 | -3,193 | 12.2K | -21% | -$105.5K |
| M | 2025-03-05 | 2025-03-05 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F - Tax | $33.05 | -1,892 | 14.8K | -11% | -$62.5K |
| DM | 2025-02-26 | 2025-02-26 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F - Tax | $39.48 | -2,885 | 13.9K | -17% | -$113.9K |
| DM | 2025-02-26 | 2025-02-26 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $0.00 | +5,760 | 14.9K | +63% | $0 |
| D | 2025-02-24 | 2025-02-21 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | +1,875 | 8,780 | +27% | $0 |
| D | 2025-02-24 | 2025-02-21 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | S - Sale+OE | $39.15 | -927 | 7,853 | -11% | -$36.3K |
| DM | 2025-02-24 | 2025-02-22+ | SUPN | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +3,250 | 8,603 | +61% | $0 |
| D | 2025-02-24 | 2025-02-22 | SUPN | Sensenig Bethany | Dir | A - Grant | $0.00 | +5,369 | 5,369 | New | $0 |
| D | 2025-02-24 | 2025-02-22 | SUPN | NEWHALL CHARLES W III | Dir | A - Grant | $0.00 | +5,369 | 135.6K | +4% | $0 |
| D | 2025-02-24 | 2025-02-22 | SUPN | GEMAYEL GEORGES | Dir | A - Grant | $0.00 | +5,369 | 18.7K | +40% | $0 |
| D | 2025-02-24 | 2025-02-22 | SUPN | Barlow Carrolee | Dir | A - Grant | $0.00 | +5,369 | 22.6K | +31% | $0 |
| DM | 2025-02-24 | 2025-02-22+ | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | A - Grant | $0.00 | +6,000 | 14.1K | +74% | $0 |
| DM | 2025-02-24 | 2025-02-22+ | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +3,250 | 12.9K | +34% | $0 |
| D | 2025-02-24 | 2025-02-21 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $39.15 | -860 | 10.9K | -7% | -$33.7K |
| D | 2025-02-24 | 2025-02-21 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | +1,650 | 11.8K | +16% | $0 |
| DM | 2025-02-24 | 2025-02-22+ | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A - Grant | $0.00 | +3,875 | 9,774 | +66% | $0 |
| D | 2025-02-24 | 2025-02-21 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F - Tax | $39.15 | -552 | 9,024 | -6% | -$21.6K |
| D | 2025-02-24 | 2025-02-21 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $0.00 | +1,125 | 9,576 | +13% | $0 |
| D | 2025-02-24 | 2025-02-22 | SUPN | Hudson Frederick M. | Dir | A - Grant | $0.00 | +5,369 | 53.8K | +11% | $0 |
| D | 2025-02-05 | 2025-02-04 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $29.61 | +9,477 | 19.6K | +93% | +$280.6K |
| D | 2025-02-05 | 2025-02-04 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $39.70 | -9,477 | 10.1K | -48% | -$376.2K |
| DM | 2025-01-29 | 2025-01-27+ | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $39.62 | -3,273 | 10.1K | -24% | -$129.7K |
| DM | 2025-01-29 | 2025-01-27+ | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $29.61 | +3,273 | 10.8K | +43% | +$96.9K |
| D | 2025-01-23 | 2025-01-22 | SUPN | Hudson Frederick M. | Dir | M - OptEx | $9.13 | +20.0K | 48.4K | +70% | +$182.6K |
| DM | 2024-12-30 | 2024-12-27 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | +2,625 | 7,416 | +55% | $0 |
| DM | 2024-12-30 | 2024-12-27 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $35.59 | -1,102 | 6,595 | -14% | -$39.2K |
| DM | 2024-12-30 | 2024-12-27 | SUPN | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $35.59 | -25.2K | 946.2K | -3% | -$898.0K |
| DM | 2024-12-30 | 2024-12-27 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +52.6K | 960.2K | +6% | $0 |
| DM | 2024-12-04 | 2024-12-03 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $36.68 | -21.5K | 9,679 | -69% | -$788.4K |
| DM | 2024-12-04 | 2024-12-03 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $24.77 | +21.5K | 18.4K | New | +$532.4K |
| D | 2024-11-12 | 2024-11-08 | SUPN | GEMAYEL GEORGES | Dir | M - OptEx | $11.46 | +10.8K | 24.1K | +81% | +$123.6K |
| D | 2024-11-12 | 2024-11-08 | SUPN | GEMAYEL GEORGES | Dir | S - Sale+OE | $36.30 | -10.8K | 13.3K | -45% | -$391.6K |
| D | 2024-11-12 | 2024-11-11 | SUPN | NEWHALL CHARLES W III | Dir | M - OptEx | $9.13 | +20.0K | 141.0K | +17% | +$182.6K |
| D | 2024-11-12 | 2024-11-11 | SUPN | NEWHALL CHARLES W III | Dir | S - Sale+OE | $36.24 | -10.7K | 130.3K | -8% | -$387.8K |
| D | 2024-11-12 | 2024-11-08 | SUPN | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $36.29 | -125.0K | 926.2K | -12% | -$4.54M |
| D | 2024-11-12 | 2024-11-08 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.13 | +125.0K | 1.05M | +13% | +$1.14M |
| 2024-11-12 | 2024-11-08 | SUPN | Hudson Frederick M. | Dir | S - Sale | $36.28 | -8,722 | 28.4K | -23% | -$316.4K | |
| D | 2024-11-08 | 2024-11-07 | SUPN | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $36.68 | -125.0K | 926.2K | -12% | -$4.58M |
| D | 2024-11-08 | 2024-11-07 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.13 | +125.0K | 1.05M | +13% | +$1.14M |
| D | 2024-11-08 | 2024-11-07 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $9.13 | +15.0K | 23.2K | +183% | +$136.9K |
| D | 2024-11-08 | 2024-11-07 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | S - Sale+OE | $36.98 | -15.0K | 8,200 | -65% | -$554.7K |
| D | 2024-11-08 | 2024-11-07 | SUPN | GEMAYEL GEORGES | Dir | M - OptEx | $11.46 | +14.2K | 27.5K | +107% | +$162.9K |
| D | 2024-11-08 | 2024-11-07 | SUPN | GEMAYEL GEORGES | Dir | S - Sale+OE | $36.62 | -14.2K | 13.3K | -52% | -$520.5K |
| DM | 2024-09-17 | 2024-09-13 | SUPN | GEMAYEL GEORGES | Dir | S - Sale+OE | $31.33 | -13.9K | 13.3K | -51% | -$435.0K |
| D | 2024-09-17 | 2024-09-13 | SUPN | GEMAYEL GEORGES | Dir | M - OptEx | $11.46 | +10.0K | 23.3K | +75% | +$114.6K |
| D | 2024-09-03 | 2024-09-03 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +21.0K | 936.2K | +2% | $0 |
| D | 2024-09-03 | 2024-09-03 | SUPN | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $34.90 | -10.0K | 926.2K | -1% | -$350.6K |
| D | 2024-08-20 | 2024-08-20 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $29.57 | -572 | 9,679 | -6% | -$16.9K |
| D | 2024-08-20 | 2024-08-20 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | +1,250 | 10.3K | +14% | $0 |
| D | 2024-03-25 | 2024-03-21 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $25.30 | +14.5K | 23.1K | +169% | +$366.6K |
| D | 2024-03-25 | 2024-03-21 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $35.31 | -14.5K | 8,570 | -63% | -$511.7K |
| D | 2024-03-22 | 2024-03-20 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $35.31 | -400 | 8,570 | -4% | -$14.1K |
| D | 2024-03-22 | 2024-03-20 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $25.30 | +400 | 8,970 | +5% | +$10.1K |
| D | 2024-03-21 | 2024-03-19 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $35.31 | -12.4K | 8,570 | -59% | -$436.6K |
| D | 2024-03-21 | 2024-03-19 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $25.30 | +12.4K | 20.9K | +144% | +$312.8K |
| DM | 2024-03-15 | 2024-03-13 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $17.61 | +62.4K | 44.7K | New | +$1.10M |
| DM | 2024-03-15 | 2024-03-13 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $33.74 | -62.4K | 8,570 | -88% | -$2.10M |
| D | 2024-03-14 | 2024-03-12 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $12.98 | +3,884 | 12.5K | +45% | +$50.4K |
| D | 2024-03-14 | 2024-03-12 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $32.99 | -3,884 | 8,570 | -31% | -$128.1K |
| D | 2024-02-29 | 2024-02-28 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $0.00 | +990 | 8,239 | +14% | $0 |
| D | 2024-02-29 | 2024-02-28 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F - Tax | $27.94 | -460 | 7,779 | -6% | -$12.9K |
| D | 2024-02-29 | 2024-02-28 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +35.0K | 932.0K | +4% | $0 |
| D | 2024-02-29 | 2024-02-28 | SUPN | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $27.94 | -16.8K | 915.2K | -2% | -$469.1K |
| D | 2024-02-28 | 2024-02-26 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $30.21 | -5,000 | 8,570 | -37% | -$151.1K |
| D | 2024-02-28 | 2024-02-26 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $9.13 | +5,000 | 13.6K | +58% | +$45.7K |
| D | 2024-02-27 | 2024-02-23 | SUPN | NEWHALL CHARLES W III | Dir | A - Grant | $0.00 | +3,886 | 121.0K | +3% | $0 |
| D | 2024-02-27 | 2024-02-23 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F - Tax | $29.06 | -937 | 7,249 | -11% | -$27.2K |
| D | 2024-02-27 | 2024-02-23 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A - Grant | $0.00 | +1,875 | 8,186 | +30% | $0 |
| D | 2024-02-27 | 2024-02-23 | SUPN | Barlow Carrolee | Dir | A - Grant | $0.00 | +3,886 | 17.2K | +29% | $0 |
| D | 2024-02-27 | 2024-02-23 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $29.06 | -638 | 8,570 | -7% | -$18.5K |
| D | 2024-02-27 | 2024-02-23 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +1,250 | 9,208 | +16% | $0 |
| D | 2024-02-27 | 2024-02-23 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | F - Tax | $29.06 | -1,314 | 7,190 | -15% | -$38.2K |
| D | 2024-02-27 | 2024-02-23 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | A - Grant | $0.00 | +2,500 | 8,504 | +42% | $0 |
| D | 2024-02-27 | 2024-02-23 | SUPN | Hudson Frederick M. | Dir | A - Grant | $0.00 | +3,886 | 37.1K | +12% | $0 |
| D | 2024-02-27 | 2024-02-23 | SUPN | SIEBERT JOHN M | Dir | A - Grant | $0.00 | +3,886 | 87.9K | +5% | $0 |
| D | 2024-02-27 | 2024-02-23 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $29.06 | -567 | 4,641 | -11% | -$16.5K |
| D | 2024-02-27 | 2024-02-23 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +1,250 | 5,208 | +32% | $0 |
| D | 2024-02-27 | 2024-02-23 | SUPN | GEMAYEL GEORGES | Dir | A - Grant | $0.00 | +3,886 | 17.2K | +29% | $0 |
| D | 2024-02-27 | 2024-02-23 | SUPN | Martin Tami Tillotson | SVP, Regulatory Affairs | A - Grant | $0.00 | +1,250 | 87.4K | +1% | $0 |
| D | 2024-02-27 | 2024-02-23 | SUPN | Martin Tami Tillotson | SVP, Regulatory Affairs | F - Tax | $29.06 | -485 | 86.9K | -0.6% | -$14.1K |
| D | 2024-02-26 | 2024-02-22 | SUPN | Martin Tami Tillotson | SVP, Regulatory Affairs | F - Tax | $27.94 | -246 | 86.2K | -0.3% | -$6,873 |
| D | 2024-02-26 | 2024-02-22 | SUPN | Martin Tami Tillotson | SVP, Regulatory Affairs | A - Grant | $0.00 | +750 | 86.4K | +0.9% | $0 |
| D | 2024-02-26 | 2024-02-22 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +750 | 4,261 | +21% | $0 |
| D | 2024-02-26 | 2024-02-22 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $27.94 | -303 | 3,958 | -7% | -$8,466 |
| D | 2024-02-26 | 2024-02-22 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F - Tax | $27.94 | -335 | 6,311 | -5% | -$9,360 |
| D | 2024-02-26 | 2024-02-22 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A - Grant | $0.00 | +750 | 6,646 | +13% | $0 |
| D | 2024-02-26 | 2024-02-22 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | A - Grant | $0.00 | +500 | 6,004 | +9% | $0 |
| D | 2024-02-26 | 2024-02-22 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $27.94 | -372 | 7,958 | -4% | -$10.4K |
Purchase Sale Sale after option exercise All abbreviations